Article
In silicoanalysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate
1 Jan 2016
Abstract excerpt
PURPOSE: Dengue virus infection is now a global problem. Currently, there is no licensed vaccine or proven antiviral treatment against this virus. All four serotypes (1-4) of dengue virus can infect human. An effective dengue vaccine should be tetravalent to induce protective immune responses against all four serotypes. Most of dengue vaccine candidates are monovalent, or in the form of physically mixed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
